Literature DB >> 2648384

Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.

T D Meek1, B D Dayton, B W Metcalf, G B Dreyer, J E Strickler, J G Gorniak, M Rosenberg, M L Moore, V W Magaard, C Debouck.   

Abstract

Recombinant human immunodeficiency virus 1 (HIV-1) protease, purified from a bacterial expression system, processed a recombinant form of its natural substrate, Pr55gag, into protein fragments that possess molecular weights commensurate with those of the virion gag proteins. Molecular weights of the protease obtained under denaturing and nondenaturing conditions (11,000 and 22,000, respectively) and chemical crosslinking studies were consistent with a dimeric structure for the active enzyme. The protease appropriately cleaved the nonapeptide Ac-Arg-Ala-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 between the tyrosine and proline residues. HIV-1 protease was sensitive to inactivators of the aspartic proteases. The aspartic protease inactivator 1,2-epoxy-3-(4-nitrophenoxy)propane produced irreversible, time-dependent inactivation of the protease. The pH-dependent kinetics of this inactivator were consistent with the requirement of an unprotonated carboxyl group in the active site of the enzyme, suggesting that HIV-1 protease is also an aspartic protease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648384      PMCID: PMC286800          DOI: 10.1073/pnas.86.6.1841

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Biochemical properties of p15-associated protease in an avian RNA tumor virus.

Authors:  K J Dittmar; K Moelling
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Mechanism of acid protease catalysis based on the crystal structure of penicillopepsin.

Authors:  M N James; I N Hsu; L T Delbaere
Journal:  Nature       Date:  1977-06-30       Impact factor: 49.962

4.  The carboxylate ion in the active center of pepsin.

Authors:  J A Hartsuck; J Tang
Journal:  J Biol Chem       Date:  1972-04-25       Impact factor: 5.157

5.  Specific and irreversible inactivation of pepsin by substrate-like epoxides.

Authors:  J Tang
Journal:  J Biol Chem       Date:  1971-07-25       Impact factor: 5.157

6.  Determination of molecular weights and frictional ratios of proteins in impure systems by use of gel filtration and density gradient centrifugation. Application to crude preparations of sulfite and hydroxylamine reductases.

Authors:  L M Siegel; K J Monty
Journal:  Biochim Biophys Acta       Date:  1966-02-07

7.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

8.  Physicochemical characterization and specificity of the murine leukaemia virus Pr65gag proteolytic factor.

Authors:  Y Yoshinaka; R B Luftig
Journal:  J Gen Virol       Date:  1980-06       Impact factor: 3.891

9.  Amino acid sequence of p15 from avian myeloblastosis virus complex.

Authors:  R T Sauer; D W Allen; H D Niall
Journal:  Biochemistry       Date:  1981-06-23       Impact factor: 3.162

10.  Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody.

Authors:  J Hansen; S Billich; T Schulze; S Sukrow; K Moelling
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  38 in total

1.  Production of cytotoxic proteins in Escherichia coli: a fermentation process for producing enzymatically active HIV-1 protease.

Authors:  W K Herber; F J Bailey; C E Carty; J C Heimbach; R Z Maigetter
Journal:  Appl Microbiol Biotechnol       Date:  1991-11       Impact factor: 4.813

2.  Insights into saquinavir resistance in the G48V HIV-1 protease: quantum calculations and molecular dynamic simulations.

Authors:  Kitiyaporn Wittayanarakul; Ornjira Aruksakunwong; Suwipa Saen-oon; Wasun Chantratita; Vudhichai Parasuk; Pornthep Sompornpisut; Supot Hannongbua
Journal:  Biophys J       Date:  2004-11-12       Impact factor: 4.033

3.  Stability and activity of human immunodeficiency virus protease: comparison of the natural dimer with a homologous, single-chain tethered dimer.

Authors:  Y S Cheng; F H Yin; S Foundling; D Blomstrom; C A Kettner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Strategies for assessing proton linkage to bimolecular interactions by global analysis of isothermal titration calorimetry data.

Authors:  Nathan P Coussens; Peter Schuck; Huaying Zhao
Journal:  J Chem Thermodyn       Date:  2012-09-01       Impact factor: 3.178

5.  Insights into amprenavir resistance in E35D HIV-1 protease mutation from molecular dynamics and binding free-energy calculations.

Authors:  Heike Meiselbach; Anselm H C Horn; Thomas Harrer; Heinrich Sticht
Journal:  J Mol Model       Date:  2006-06-23       Impact factor: 1.810

6.  Isolation and characterization of recombinant Drosophila Copia aspartic proteinase.

Authors:  Senarath B P Athauda; Katsuji Yoshioka; Tadayoshi Shiba; Kenji Takahashi
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

7.  Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation.

Authors:  H G Kräusslich
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants.

Authors:  W Shao; L Everitt; M Manchester; D D Loeb; C A Hutchison; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

9.  Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli.

Authors:  E Z Baum; G A Bebernitz; Y Gluzman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

10.  Development of activity assays for high-volume evaluation of human immunodeficiency virus (HIV) protease inhibitors in rat serum: results with ditekiren.

Authors:  K F Wilkinson; B D Rush; S K Sharma; D B Evans; M J Ruwart; J M Friis; M J Bohanon; P K Tomich
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.